Principal Group Leader
Francis Crick Institute;
Former Chief Scientist
Cancer Research UK
London, United Kingdom
For discoveries in tumor suppressor biology and cancer metabolism, contributing to the understanding of metabolic adaptations that sustain cancer growth and identifying novel therapeutic vulnerabilities. Dr. Vousden’s research elucidated the regulation of p53 by MDM2, defined key metabolic dependencies in cancer cells, and revealed the impact of dietary interventions on tumor progression. Her insights into reactive oxygen species in tumor development and metastasis have informed therapeutic strategies, while her scientific leadership and translational impact have and continue to advance cancer biology.
The AACR-G.H.A. Clowes Award for Outstanding Basic Cancer Research was established by the AACR and Eli Lilly and Co. in 1961 to honor Dr. G.H.A. Clowes, who was a founding member of the AACR and a research director at Eli Lilly. The award is intended to recognize an individual who has made outstanding recent accomplishments in basic cancer research. To learn more, please visit the press release.
View Dr. Vousden’s Fellows of the AACR Academy page.
View Past Recipients.